Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-016994

Chief Operating Officer sold 20,000 shares at $6.73 ($134,600)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2018-03-05 Sale −20,000 $6.73 $134,600 908,356 D: show line 1 in the form
Open-market sales · 20,000 sh · avg $6.73 · $134,600
Loading xslF345X03/doc4.xml…